Our Stories Rx

08/27/2026

: Federal reform efforts are back in this fall.

Read more: https://www.ajmc.com/view/senate-unveils-sweeping-bill-to-reform-340b-drug-program

08/25/2026

"Medical innovations, such as the skin cancer vaccine, are being created in spite of the political class, not because of it."

benefit from competitive research environments: https://www.washingtonpost.com/opinions/2026/08/21/moderna-cancer-vaccine-is-thanks-free-market/

08/20/2026

A fantastic recap of the state of reform in 2026 and what is possible in terms of protections at the state level: https://www.amcp.org/blog/5-states-driving-pbm-reform-2026

08/18/2026

"With no requirement to route savings to patients and no window into how the money is used, the results were predictable. Hospitals buy discounted drugs and resell them for 10 times or more what they paid."

Congress, it's time for transparency: https://www.washingtonexaminer.com/op-eds/4681897/340b-hospital-drug-discount-program-reform-trump-hhs/

08/13/2026

" is essential to assisting CEs with stretching resources and providing care in rural and medically underserved communities. But preserving 340B does not require preserving every administrative convention developed over its three-decade history."

https://www.americanactionforum.org/weekly-checkup/strengthening-340b-through-the-rebate-pilot-program/?utm_source=American+Action+Forum+Emails&utm_campaign=a3f23093d3-EMAIL_CAMPAIGN_2018_08_31_01_22_COPY_01&utm_medium=email&utm_term=0_64783a8335-a3f23093d3-267126413

08/11/2026

"In seventeen years as CEO, Cordani transformed a company, which as recently as the 1980s had a relatively inconsequential share of the U.S. health insurance business, to a Fortune 15 health care conglomerate."

How a is made: https://healthcareuncovered.substack.com/p/the-ceo-who-built-modern-cigna?utm_source=post-email-title&publication_id=255152&post_id=209070874&utm_campaign=email-post-title&isFreemail=true&r=18befa&triedRedirect=true&utm_medium=email

08/06/2026

"Public hospitals were more likely to expand outpatient psychiatric services after joining the program.

For nonprofit hospitals, however, participation in the Program was not associated with an increase in unprofitable services."

New findings:

By the Health Equity Collaborative The 340B Drug Pricing Program was created more than three decades ago with a straightforward goal: help safety-net providers stretch limited resources so they can better serve low-income and uninsured patients. Today, the program has grown into one of the...

08/04/2026

Tune in TOMORROW for Beyond the Policy: Examining the Rebate Pilot Through the Patient Lens

From 2–3 PM ET, patient advocacy leaders will discuss the 340B rebate pilot and its potential implications for patients and communities.

RSVP today: https://us06web.zoom.us/webinar/register/WN_sYhXe5UOT5OVpNiyZJy3_Q

07/30/2026

"Reduced government-driven consolidation pressure should help preserve competition and moderate some of the cost growth affecting premiums in employer-sponsored insurance and other private coverage, where 340B-related costs have been significant."

https://paragoninstitute.org/medicare/cmss-2027-opps-proposed-rule-advances-340b-payment-reform-site-neutrality-and-program-integrity/

07/28/2026

"Opaque and disparate plan bids, drug prices, and tiering decisions controlled by the PBM intermediaries all tilt the system the same way: toward PBM incentives, and often away from taxpayers, employers, providers, and patients."

https://www.pbmaccountability.org/post/how-pbms-turn-cheap-generic-drugs-into-specialty-gold-mines